These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 5354488)

  • 1. [On the therapy of liver diseases with ornithine aspartate].
    Melzer H; Weber D; Wotzka R
    Med Klin; 1969; 64(35):1541-4. PubMed ID: 5354488
    [No Abstract]   [Full Text] [Related]  

  • 2. [Further clinical experiences with ornithine aspartate in liver diseases].
    Wotzka R; Weber D
    Ther Ggw; 1972 Mar; 111(3):400-12. PubMed ID: 5024593
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of blood ammonia level in liver diseases].
    Engelmann L
    Z Gesamte Inn Med; 1970 Dec; 25(23):1049-55. PubMed ID: 4104436
    [No Abstract]   [Full Text] [Related]  

  • 4. Normotest in acute hepatitis and chronic liver disease.
    Ockerman PA; Braconier JH; Eriksson O
    Scand J Gastroenterol Suppl; 1973; 19():83-91. PubMed ID: 4515643
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic trial with methylphenobarbital (Prominal), an enzyme inducer, in liver disease. A contribution to the question of hepatotoxicity of barbiturates.
    Glogner P; Massarrat S; Henrichs HR
    Acta Hepatosplenol; 1971; 18(5):394-7. PubMed ID: 5112056
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thiomesterone and liver function].
    Pickert H
    Med Klin; 1968 Aug; 63(31):1222-6. PubMed ID: 5719699
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experiences with ornithine-aspartate in liver diseases].
    Aschke J
    Med Welt; 1969 Mar; 12():657-62. PubMed ID: 5767441
    [No Abstract]   [Full Text] [Related]  

  • 8. [Plasma tyrosine level in liver diseases].
    Selmair H; Langness U; Zimmermann J; Herborn U
    Med Klin; 1971 Jun; 66(30):1049-52. PubMed ID: 5569262
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical experiences in liver diseases (specially in patients with fatty liver due to alcoholism and food poisoning) under monotherapy with ornithine aspartate].
    Hunold W
    Z Allgemeinmed; 1973 Apr; 49(10):469-72. PubMed ID: 4580434
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical study on the effects of L-ornithine-L-aspartate on liver dysfunction].
    Kosozu K
    Iryo; 1966 Apr; 20(4):339-46. PubMed ID: 5974192
    [No Abstract]   [Full Text] [Related]  

  • 11. [Glucocorticoids in chronic liver diseases].
    Maier KP; Talke H; Gerok W
    Dtsch Med Wochenschr; 1975 Mar; 100(11):560-3. PubMed ID: 1116441
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical investigation of silymarin in chronic liver diseases (author's transl)].
    Realini S; Gonvers JJ; Hofstetter JR
    Schweiz Rundsch Med Prax; 1975 May; 64(19):595-8. PubMed ID: 51497
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ergometric studies of body tolerance in patients with chronic liver disease].
    Franken FH; Wiechers B
    Dtsch Med Wochenschr; 1973 Mar; 98(11):528-31. PubMed ID: 4694994
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of treatment with nucleotides and aspartic acid in chronic liver diseases].
    Iencica R
    Med Interna (Bucur); 1972 Dec; 24(12):1449-53. PubMed ID: 4655566
    [No Abstract]   [Full Text] [Related]  

  • 15. [Influence of ornithine aspartate on the experimentally induced hyperammoniemia. Clinico-experimental study].
    Henglein-Ottermann D
    Ther Ggw; 1976 Sep; 115(9):1504-18. PubMed ID: 968783
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-term therapy of liver diseases].
    Markoff N
    Wien Med Wochenschr; 1972 Feb; 122(7):95-9. PubMed ID: 4621921
    [No Abstract]   [Full Text] [Related]  

  • 17. Aspartic acid in the treatment of chronic hepatitis.
    Fodor O; Barbarino F; Cotul S
    Acta Hepatosplenol; 1971; 18(5):383-94. PubMed ID: 5112055
    [No Abstract]   [Full Text] [Related]  

  • 18. [Reflections on prednisone therapy of patients with liver diseases].
    Teichmann W
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):25-7. PubMed ID: 5501421
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results of glucocorticoid therapy in liver diseases].
    Möller E; Brinkmann W; Weber O
    Med Welt; 1967 Apr; 14():884-9. PubMed ID: 5585085
    [No Abstract]   [Full Text] [Related]  

  • 20. [Silymarin action in liver diseases].
    Hammerl H; Pichler O; Studlar M
    Med Klin; 1971 Sep; 66(36):1204-8. PubMed ID: 5096207
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.